Contact Us
Isosorbide Mononitrate Tablet Global Market Report 2025
Global Isosorbide Mononitrate Tablet Market Report 2025
Item added to cart!

Published : December 2025

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF
Purchase This Report

Isosorbide Mononitrate Tablet Global Market Report 2025

By Dosage Form (Immediate-Release Tablets, Extended-Release Tablets), By Indication Type (Angina Pectoris, Heart Failure, Hypertension), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Isosorbide Mononitrate Tablet Market Overview

• Isosorbide Mononitrate Tablet market size has reached to $1.14 billion in 2024

• Expected to grow to $1.47 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%

• Growth Driver: The Rising Prevalence Of Cardiovascular Diseases Is Fueling The Market Growth Due To Increasing Demand For Effective Heart Disease Management Solutions

• Market Trend: The Role Of Extended-Release Tablets In Improving Patient Compliance And Treatment Outcomes

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Isosorbide Mononitrate Tablet Market?

Isosorbide mononitrate tablet is a long-acting nitrate medication primarily used to prevent and control chest pain (angina) associated with coronary artery disease. It works by relaxing and dilating blood vessels, particularly in the heart, allowing for increased blood and oxygen flow while reducing the heart's workload. Unlike fast-acting nitrates used for immediate relief, isosorbide mononitrate is taken regularly as a maintenance therapy to reduce the frequency and severity of angina attacks and improve overall cardiovascular function.

The main dosage forms of isosorbide mononitrate tablets are immediate-release tablets and extended-release tablets. Immediate-release tablets are designed to dissolve quickly, delivering rapid absorption for fast relief, particularly in conditions such as angina. These tablets are used for various indications, such as angina pectoris, heart failure, and hypertension, and are distributed through various channels, such as hospital pharmacies, retail pharmacies, and online pharmacies.

Isosorbide Mononitrate Tablet Market Size and growth rate 2025 to 2029: Graph

What Is The Isosorbide Mononitrate Tablet Market Size 2025 And Growth Rate?

The isosorbide mononitrate tablet market size has grown strongly in recent years. It will grow from $1.14 billion in 2024 to $1.2 billion in 2025 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to the growing elderly population, increasing incidence of heart-related conditions, increased awareness of heart health, generic drug availability, and public health campaigns.

What Is The Isosorbide Mononitrate Tablet Market Growth Forecast?

The isosorbide mononitrate tablet market size is expected to see strong growth in the next few years. It will grow to $1.47 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to regulatory approvals and patent expirations, increasing adoption of generic drugs, growth in lifestyle-related risk factors, government initiatives for cardiovascular disease management, improvements in diagnostic infrastructure, and awareness campaigns. Major trends in the forecast period include advancements in extended-release formulations, technological innovations, digital health platforms and e-commerce, integration of digital health technologies, and combining isosorbide mononitrate with other cardiovascular drugs.

The forecast of 5.3% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. cardiac care by increasing costs for angina management medications manufactured in India and Puerto Rico, potentially leading to treatment gaps and higher cardiovascular disease management expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Isosorbide Mononitrate Tablet Market Segmented?

1) By Dosage Form: Immediate-Release Tablets, Extended-Release Tablets

2) By Indication Type: Angina Pectoris, Heart Failure, Hypertension

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Immediate-Release Tablets: Low-Dose, Single Strength Tablets, Combination With Other Drugs

2) By Extended-Release Tablets: Moderate-Dose, High-Dose, Once-Daily Formulation, Twice-Daily Formulation

What Is Driving The Isosorbide Mononitrate Tablet Market? The Rising Prevalence Of Cardiovascular Diseases Is Fueling The Market Growth Due To Increasing Demand For Effective Heart Disease Management Solutions

The rising prevalence of cardiovascular diseases is expected to propel the growth of the isosorbide mononitrate tablet market going forward. Cardiovascular diseases (CVDs) refer to a group of disorders affecting the heart and blood vessels, including coronary artery disease, heart failure, and hypertension. The rising prevalence of cardiovascular diseases is primarily attributed to unhealthy diets, which often include high levels of saturated fats, trans fats, sodium, and added sugars, leading to conditions such as obesity, hypertension, and high cholesterol. Isosorbide mononitrate tablets help manage cardiovascular diseases by relaxing and widening blood vessels, which improves blood flow and reduces the heart's workload, thereby alleviating chest pain (angina), lowering blood pressure, and enhancing oxygen delivery to the heart muscle. For instance, in December 2023, according to the Australian Institute of Health and Welfare, an Australia-based government agency, doctor-certified deaths attributed to coronary heart disease (CHD) increased to 14,100 in 2021 and further rose to 14,900 in 2022. Therefore, the rising prevalence of cardiovascular diseases is driving the growth of the isosorbide mononitrate tablet industry.

What Is Driving The Isosorbide Mononitrate Tablet Market? The Rise In Online Pharmacies Is Fueling Market Growth Due To Increasing Consumer Demand For Convenience And Accessibility

The rise in online pharmacies is expected to propel the growth of the isosorbide mononitrate tablet market going forward. Online pharmacies refer to digital platforms or websites that allow consumers to purchase prescription and over-the-counter medications over the internet. The rise in online pharmacies is primarily due to increasing consumer demand for convenience, affordability, and accessibility to medications and healthcare products without the need to visit physical stores. Online pharmacies facilitate convenient access to isosorbide mononitrate tablets by offering home delivery, competitive pricing, and improved availability, especially for patients managing chronic conditions. For instance, in September 2023, according to a survey conducted on 1,500 Americans by the Alliance for Safe Online Pharmacies (ASOP), a US-based non-profit organization, 52% of Americans aged 18 and older reported having previously used an online pharmacy, reflecting a 10% increase from 2021 and a 17% increase from 2020. Therefore, the rise in online pharmacies is driving the growth of the isosorbide mononitrate tablet industry.

Who Are The Major Players In The Global Isosorbide Mononitrate Tablet Market?

Major companies operating in the isosorbide mononitrate tablet market are Pfizer Inc., Merck & Co. Inc., AstraZeneca PLC, Abbott Laboratories Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Zydus Lifesciences Limited, Recipeharm, Torrent Pharmaceuticals Ltd., Micro Labs Ltd., Lotus Pharmaceuticals, Healthy Inc., Qilu Pharmaceutical Co., Ltd, Lunan Pharmaceutical Group, Johnlee Pharmaceuticals Pvt. Ltd., Niksan Pharmaceutical, Shandong Keyuan Pharmaceutical, Prevego Healthcare & Research Private Limited.

What Are The Key Trends Of The Global Isosorbide Mononitrate Tablet Market? The Role Of Extended-Release Tablets In Improving Patient Compliance And Treatment Outcomes

Major companies operating in the isosorbide mononitrate tablet market are focusing on developing innovative products such as extended-release (ER) formulations to enhance patient compliance, provide sustained therapeutic effects, and optimize treatment outcomes for conditions such as angina pectoris. An extended-release formulation is an advanced drug delivery system that allows for the gradual release of medication over an extended period, reducing dosing frequency and maintaining consistent blood levels. For instance, in February 2024, Zydus Lifesciences Limited, an India-based pharmaceutical manufacturing company, received approval from the United States Food and Drug Administration (USFDA) to manufacture and market isosorbide mononitrate extended-release tablets USP in strengths of 30 mg, 60 mg, and 120 mg. These tablets are used to prevent chest pain (angina) in patients with coronary artery disease and are equivalent to the reference listed drug (RLD), imdur extended-release tablets.

Need data on a specific region in this market?

What Is The Regional Outlook For The Global Isosorbide Mononitrate Tablet Market?

North America was the largest region in the isosorbide mononitrate tablet market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Isosorbide Mononitrate Tablet Market?

The isosorbide mononitrate tablet market consists of sales of dilatrate-SR, isochron, monoket, and imdur, pediatric and geriatric-adjusted tablets, and combination products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Isosorbide Mononitrate Tablet Industry?

The isosorbide mononitrate tablet market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the isosorbide mononitrate tablet industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Isosorbide Mononitrate Tablet Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $1.2 billion
Revenue Forecast In 2034 $1.47 billion
Growth Rate CAGR of 5.3% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The isosorbide mononitrate tablet market covered in this report is segmented –
1) By Dosage Form: Immediate-Release Tablets, Extended-Release Tablets
2) By Indication Type: Angina Pectoris, Heart Failure, Hypertension
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies Subsegments:
1) By Immediate-Release Tablets: Low-Dose, Single Strength Tablets, Combination With Other Drugs
2) By Extended-Release Tablets: Moderate-Dose, High-Dose, Once-Daily Formulation, Twice-Daily Formulation
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Merck & Co. Inc., AstraZeneca PLC, Abbott Laboratories Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Zydus Lifesciences Limited, Recipeharm, Torrent Pharmaceuticals Ltd., Micro Labs Ltd., Lotus Pharmaceuticals, Healthy Inc., Qilu Pharmaceutical Co., Ltd, Lunan Pharmaceutical Group, Johnlee Pharmaceuticals Pvt. Ltd., Niksan Pharmaceutical, Shandong Keyuan Pharmaceutical, Prevego Healthcare & Research Private Limited.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Isosorbide Mononitrate Tablet Market Characteristics

3. Isosorbide Mononitrate Tablet Market Trends And Strategies

4. Isosorbide Mononitrate Tablet Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Isosorbide Mononitrate Tablet Growth Analysis And Strategic Analysis Framework

5.1. Global Isosorbide Mononitrate Tablet PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Isosorbide Mononitrate Tablet Market Growth Rate Analysis

5.4. Global Isosorbide Mononitrate Tablet Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Isosorbide Mononitrate Tablet Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Isosorbide Mononitrate Tablet Total Addressable Market (TAM)

6. Isosorbide Mononitrate Tablet Market Segmentation

6.1. Global Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Immediate-Release Tablets

Extended-Release Tablets

6.2. Global Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Angina Pectoris

Heart Failure

Hypertension

6.3. Global Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

6.4. Global Isosorbide Mononitrate Tablet Market, Sub-Segmentation Of Immediate-Release Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Low-Dose

Single Strength Tablets

Combination With Other Drugs

6.5. Global Isosorbide Mononitrate Tablet Market, Sub-Segmentation Of Extended-Release Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Moderate-Dose

High-Dose

Once-Daily Formulation

Twice-Daily Formulation

7. Isosorbide Mononitrate Tablet Market Regional And Country Analysis

7.1. Global Isosorbide Mononitrate Tablet Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Isosorbide Mononitrate Tablet Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Isosorbide Mononitrate Tablet Market

8.1. Asia-Pacific Isosorbide Mononitrate Tablet Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Isosorbide Mononitrate Tablet Market

9.1. China Isosorbide Mononitrate Tablet Market Overview

9.2. China Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Isosorbide Mononitrate Tablet Market

10.1. India Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Isosorbide Mononitrate Tablet Market

11.1. Japan Isosorbide Mononitrate Tablet Market Overview

11.2. Japan Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Isosorbide Mononitrate Tablet Market

12.1. Australia Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Isosorbide Mononitrate Tablet Market

13.1. Indonesia Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Isosorbide Mononitrate Tablet Market

14.1. South Korea Isosorbide Mononitrate Tablet Market Overview

14.2. South Korea Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Isosorbide Mononitrate Tablet Market

15.1. Western Europe Isosorbide Mononitrate Tablet Market Overview

15.2. Western Europe Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Isosorbide Mononitrate Tablet Market

16.1. UK Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Isosorbide Mononitrate Tablet Market

17.1. Germany Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Isosorbide Mononitrate Tablet Market

18.1. France Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Isosorbide Mononitrate Tablet Market

19.1. Italy Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Isosorbide Mononitrate Tablet Market

20.1. Spain Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Isosorbide Mononitrate Tablet Market

21.1. Eastern Europe Isosorbide Mononitrate Tablet Market Overview

21.2. Eastern Europe Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Isosorbide Mononitrate Tablet Market

22.1. Russia Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Isosorbide Mononitrate Tablet Market

23.1. North America Isosorbide Mononitrate Tablet Market Overview

23.2. North America Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Isosorbide Mononitrate Tablet Market

24.1. USA Isosorbide Mononitrate Tablet Market Overview

24.2. USA Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Isosorbide Mononitrate Tablet Market

25.1. Canada Isosorbide Mononitrate Tablet Market Overview

25.2. Canada Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Isosorbide Mononitrate Tablet Market

26.1. South America Isosorbide Mononitrate Tablet Market Overview

26.2. South America Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Isosorbide Mononitrate Tablet Market

27.1. Brazil Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Isosorbide Mononitrate Tablet Market

28.1. Middle East Isosorbide Mononitrate Tablet Market Overview

28.2. Middle East Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Isosorbide Mononitrate Tablet Market

29.1. Africa Isosorbide Mononitrate Tablet Market Overview

29.2. Africa Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Isosorbide Mononitrate Tablet Market Competitive Landscape And Company Profiles

30.1. Isosorbide Mononitrate Tablet Market Competitive Landscape

30.2. Isosorbide Mononitrate Tablet Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Isosorbide Mononitrate Tablet Market Other Major And Innovative Companies

31.1. Sun Pharmaceutical Industries Ltd.

31.2. Aurobindo Pharma Ltd.

31.3. Cipla Ltd.

31.4. Zydus Lifesciences Limited

31.5. Recipeharm

31.6. Torrent Pharmaceuticals Ltd.

31.7. Micro Labs Ltd.

31.8. Lotus Pharmaceuticals

31.9. Healthy Inc.

31.10. Qilu Pharmaceutical Co., Ltd

31.11. Lunan Pharmaceutical Group

31.12. Johnlee Pharmaceuticals Pvt. Ltd.

31.13. Niksan Pharmaceutical

31.14. Shandong Keyuan Pharmaceutical

31.15. Prevego Healthcare & Research Private Limited

32. Global Isosorbide Mononitrate Tablet Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Isosorbide Mononitrate Tablet Market

34. Recent Developments In The Isosorbide Mononitrate Tablet Market

35. Isosorbide Mononitrate Tablet Market High Potential Countries, Segments and Strategies

35.1 Isosorbide Mononitrate Tablet Market In 2029 - Countries Offering Most New Opportunities

35.2 Isosorbide Mononitrate Tablet Market In 2029 - Segments Offering Most New Opportunities

35.3 Isosorbide Mononitrate Tablet Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Isosorbide Mononitrate Tablet Market, Sub-Segmentation Of Immediate-Release Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Isosorbide Mononitrate Tablet Market, Sub-Segmentation Of Extended-Release Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Isosorbide Mononitrate Tablet Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Isosorbide Mononitrate Tablet Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Asia-Pacific, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: China, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: India, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Japan, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Australia, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Indonesia, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: South Korea, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Western Europe, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: UK, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Germany, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: France, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Italy, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Spain, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Eastern Europe, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Russia, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: North America, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: USA, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: Canada, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: South America, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Brazil, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Middle East, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Africa, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Pfizer Inc. Financial Performance
  • Table 77: Merck & Co. Inc. Financial Performance
  • Table 78: AstraZeneca PLC Financial Performance
  • Table 79: Abbott Laboratories Inc. Financial Performance
  • Table 80: Teva Pharmaceutical Industries Ltd. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Isosorbide Mononitrate Tablet Market, Sub-Segmentation Of Immediate-Release Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Isosorbide Mononitrate Tablet Market, Sub-Segmentation Of Extended-Release Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Isosorbide Mononitrate Tablet Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Isosorbide Mononitrate Tablet Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Asia-Pacific, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: China, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: India, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Japan, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Australia, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Indonesia, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: South Korea, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Western Europe, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: UK, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Germany, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: France, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Italy, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Spain, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Eastern Europe, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Russia, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: North America, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: USA, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: Canada, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: South America, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Brazil, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Middle East, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Africa, Isosorbide Mononitrate Tablet Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Isosorbide Mononitrate Tablet Market, Segmentation By Indication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Isosorbide Mononitrate Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Pfizer Inc. Financial Performance
  • Figure 77: Merck & Co. Inc. Financial Performance
  • Figure 78: AstraZeneca PLC Financial Performance
  • Figure 79: Abbott Laboratories Inc. Financial Performance
  • Figure 80: Teva Pharmaceutical Industries Ltd. Financial Performance

Frequently Asked Questions

Isosorbide mononitrate tablet is a long-acting nitrate medication primarily used to prevent and control chest pain (angina) associated with coronary artery disease. It works by relaxing and dilating blood vessels, particularly in the heart, allowing for increased blood and oxygen flow while reducing the heart's workload. Unlike fast-acting nitrates used for immediate relief, isosorbide mononitrate is taken regularly as a maintenance therapy to reduce the frequency and severity of angina attacks and improve overall cardiovascular function. For further insights on this market, request a sample here

The market major growth driver - The Rising Prevalence Of Cardiovascular Diseases Is Fueling The Market Growth Due To Increasing Demand For Effective Heart Disease Management Solutions. For further insights on this market, request a sample here

The isosorbide mononitrate tablet market size has grown steadily in recent years. It will grow from $1.14 billion in 2024 to $1.2 billion in 2025 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to the growing elderly population, increasing incidence of heart-related conditions, increased awareness of heart health, generic drug availability, and public health campaigns. The isosorbide mononitrate tablet market size is expected to see strong growth in the next few years. It will grow to " $1.47 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to regulatory approvals and patent expirations, increasing adoption of generic drugs, growth in lifestyle-related risk factors, government initiatives for cardiovascular disease management, improvements in diagnostic infrastructure, and awareness campaigns. Major trends in the forecast period include advancements in extended-release formulations, technological innovations, digital health platforms and e-commerce, integration of digital health technologies, and combining isosorbide mononitrate with other cardiovascular drugs. For further insights on this market, request a sample here

The isosorbide mononitrate tabletmarket covered in this report is segmented –
1) By Dosage Form: Immediate-Release Tablets; Extended-Release Tablets
2) By Indication Type: Angina Pectoris; Heart Failure; Hypertension
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies Subsegments:
1) By Immediate-Release Tablets: Low-Dose; Single Strength Tablets; Combination With Other Drugs
2) By Extended-Release Tablets: Moderate-Dose; High-Dose; Once-Daily Formulation; Twice-Daily Formulation For further insights on this market,
request a sample here

North America was the largest region in the isosorbide mononitrate tablet market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the isosorbide mononitrate tablet market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the isosorbide mononitrate tablet market are Pfizer Inc., Merck & Co. Inc., AstraZeneca PLC, Abbott Laboratories Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Zydus Lifesciences Limited, Recipeharm, Torrent Pharmaceuticals Ltd., Micro Labs Ltd., Lotus Pharmaceuticals, Healthy Inc., Qilu Pharmaceutical Co., Ltd, Lunan Pharmaceutical Group, Johnlee Pharmaceuticals Pvt. Ltd., Niksan Pharmaceutical, Shandong Keyuan Pharmaceutical, Prevego Healthcare & Research Private Limited. . For further insights on this market, request a sample here.

Major trends in this market include The Role Of Extended-Release Tablets In Improving Patient Compliance And Treatment Outcomes. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon